Perspective
Our work in Perspective
-
Those Previously Infected with COVID-19 Should Delay Getting a Vaccination
Policymakers should ask the millions of people who have already survived the coronavirus infection to step to the back of the line for vaccines, argue Neeraj Sood and colleagues in CalMatters.
Categorized in -
Travel Bans Should Be Based on Evidence, Not Politics or Fear
Scientific evidence suggests that extending travel bans will not make Americans safer, and instead result in adverse consequences for millions of family members who have been separated for over 10 months.
Categorized in -
The U.S. is Overlooking this Powerful Tool to Loosen the COVID-19 Vaccine Logjam
Local, independent pharmacies are being overlooked, and that’s a mistake.
Categorized in -
Legalizing Marijuana, once a Pipe Dream on Capitol Hill, Takes an Important Step Forward
Rosalie Liccardo Pacula writes about strengths and weakness in the MORE Act along with additional policy ideas that could strengthen regulation and better protect consumers.
Categorized in -
Will the Rebate Rule need Extra Innings?
The publication of the final rebate rule is an important milestone in this administration’s drug pricing journey. However, many challenges remain.
Categorized in -
Election Polls Are More Accurate if They ask Participants How Others Will Vote
Traditional polls ask people whom they would vote for if the election were today, or for the percent chance that they might vote for particular candidates. But asking people about the political preferences of social circles and communities might yield more accurate results.
Categorized in -
Understanding The Latest ACO “Savings”: Curb Your Enthusiasm And Sharpen Your Pencils—Part 2
In this post, the authors lay out key considerations for improving the MSSP over the long haul with the objective of helping get a repeatedly derailed conversation back on track.
Categorized in -
Understanding The Latest ACO “Savings”: Curb Your Enthusiasm And Sharpen Your Pencils—Part 1
Did the MSSP save Medicare $1.2 billion in 2019? No—not even close. Might the true net savings be close to zero? Quite possibly.
Categorized in -
Approving the Pfizer Vaccine Would, Finally, Mark the End of the Beginning
The news from Pfizer suggests we may be at the end of the beginning of the pandemic. We now have even more reason to redouble our pandemic control and mitigation efforts, so that we can limit the disability and death from new infections until vaccines become available.
Categorized in -
The COVID-19 Vaccines Are Coming. Here’s How They Should Be Rolled Out
Well before Operation Warp Speed delivers products en masse, we need to be prepared to distribute them effectively.
Categorized in